Adverse drug event risk assessment by the virtual addition of COVID‐19 repurposed drugs to Medicare and commercially insured patients' drug regimens: A drug safety simulation study

• Main Authors: Matt K. Smith (Author), Ravil Bikmetov (Author), Sweilem B. Al Rihani (Author), Malavika Deodhar (Author), Matthew Hafermann (Author), Pamela Dow (Author), Jacques Turgeon (Author), Veronique Michaud (Author)
• Format: Book
• Published: Wiley, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Drug safety is generally established from clinical trials, by pharmacovigilance programs and during observational phase IV safety studies according to drug intended or approved indications. The objective of this study was to estimate the risk of potential adverse drug events (ADEs) associat...